XML 73 R54.htm IDEA: XBRL DOCUMENT v3.25.1
Restructuring, Business Transformation and Other Cost Saving Initiatives - Narrative (Details)
$ in Millions
3 Months Ended
Sep. 26, 2023
USD ($)
Mar. 31, 2025
USD ($)
Employee
Mar. 31, 2024
USD ($)
Sep. 30, 2023
ft²
Jul. 31, 2023
USD ($)
Reata Pharmaceuticals, Inc          
Restructuring Cost and Reserve [Line Items]          
Operating lease area | ft²       327,400  
Lease term       16 years  
Minimum          
Restructuring Cost and Reserve [Line Items]          
Restructuring and Related Cost, Expected Cost Remaining         $ 300.0
Maximum          
Restructuring Cost and Reserve [Line Items]          
Restructuring and Related Cost, Expected Cost Remaining         $ 310.0
2023 Cost Saving Initiatives          
Restructuring Cost and Reserve [Line Items]          
Expected operating expense reduction $ 1,000.0        
Expected number of positions eliminated | Employee   1,400      
Severance Costs   $ 35.3 $ 9.3    
2023 Cost Saving Initiatives | Restructuring charges          
Restructuring Cost and Reserve [Line Items]          
Severance Costs   35.3 9.3    
Reata Integration          
Restructuring Cost and Reserve [Line Items]          
Severance Costs   (0.2) 2.2    
Reata Integration | Minimum          
Restructuring Cost and Reserve [Line Items]          
Expected cost   35.0      
Reata Integration | Restructuring charges          
Restructuring Cost and Reserve [Line Items]          
Severance Costs   $ (0.2) $ 2.2